Related references
Note: Only part of the references are listed.Emerging links between pediatric lysosomal storage diseases and adult parkinsonism
Daniel Ysselstein et al.
MOVEMENT DISORDERS (2019)
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
Jianbin Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations
Gilad Yahalom et al.
PARKINSONISM & RELATED DISORDERS (2019)
LRRK2 Phosphorylation: Behind the Scenes
Tina De Wit et al.
NEUROSCIENTIST (2018)
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease
Maria Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Michael X. Henderson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
Farzaneh Atashrazm et al.
SCIENTIFIC REPORTS (2018)
LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress
Zhongcan Chen et al.
HUMAN MOLECULAR GENETICS (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
Glucocerebrosidase Mutations in Parkinson Disease
Grace O'Regan et al.
JOURNAL OF PARKINSONS DISEASE (2017)
The LRRK2-macroautophagy axis and its relevance to Parkinson's disease
Claudia Manzoni
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models
Joseph R. Mazzulli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR
Maximilian Haeussler et al.
GENOME BIOLOGY (2016)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Cellular processes associated with LRRK2 function and dysfunction
Rebecca Wallings et al.
FEBS JOURNAL (2015)
Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease
Mariana Spitz et al.
PARKINSONISM & RELATED DISORDERS (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The role of the LRRK2 gene in Parkinsonism
Jie-Qiong Li et al.
MOLECULAR NEURODEGENERATION (2014)
Interaction of LRRK2 with kinase and GTPase signaling cascades
Joon Y. Boon et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
Raquel Duran et al.
MOVEMENT DISORDERS (2013)
Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2
Nathan Pankratz et al.
ANNALS OF NEUROLOGY (2012)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Saskia Biskup et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
H Fedorow et al.
PROGRESS IN NEUROBIOLOGY (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews
J Aharon-Peretz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
